STAAR Surgical sinks as it plans to terminate sale to Alcon (STAA:NASDAQ)

STAAR Surgical sinks as it plans to terminate sale to Alcon (STAA:NASDAQ)

STAAR Surgical stock plunges 16% as Alcon merger is terminated after failed shareholder vote.

STAAR Surgical terminates proposed acquisition by Alcon

The company did not receive the necessary stockholder votes to approve the merger agreement with Alcon at the Special Meeting of Stockholders held on January 6, 2026.

STAAR Surgical terminates Alcon merger agreement

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a disputatious period between the company and its shareholders.The post STAAR Surgical terminates Alcon merger agreement appeared first on Medical Device Network.

Staar Surgical Shareholders Reject $1.6 Billion Merger - Orange County Business Journal

Staar Surgical Co. said it plans to terminate its proposed $1.6 billion sale to Alcon Inc. based on preliminary results from today’s shareholder vote. As a result, Staar will remain a standalone, publicly traded company and continue to trade on the Nasdaq under the ticker symbol “STAA.” “The Board approved the Alcon agreement because we determined that it was in the best interests of STAAR stockholders,” Chief Executive Stephen Farrell said in a…